A clinical review of drug-induced gingival overgrowths.
There is an increasing number of medications associated with gingival overgrowth. These medications are used to treat a number of common conditions in the Australian population and as such dentists can expect to manage a number of patients with medication-related gingival overgrowth. This review highlights the clinical features and management of the common overgrowths associated with anticonvulsants, immunosuppressants and the calcium channel blockers.
Marshall
R I
RI
Department of Dentistry, University of Queensland.
Bartold
P M
PM
D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects; D001315:Australia; D002121:Calcium Channel Blockers / Q000009:adverse effects; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D004347:Drug Interactions; D019214:Gingival Overgrowth / Q000139:chemically induced* / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D009910:Oral Hygiene; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects
D000927:Anticonvulsants; D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D010672:Phenytoin; D016572:Cyclosporine